← FDA DRUG APPROVALS

FDA ANDA · ANDA086866

CHLORPROPAMIDE

Sponsor: WATSON LABS

APPLICATION
ANDA086866
TYPE
ANDA
LATEST ACTION
1986-08-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORPROPAMIDEDiscontinued
CHLORPROPAMIDE 250MG · TABLET · ORAL

Approval history

1986-08-20Manufacturing (CMC) · Supplement 9AP
1986-08-20Manufacturing (CMC) · Supplement 7AP
1986-08-20Manufacturing (CMC) · Supplement 8AP
1986-08-20Manufacturing (CMC) · Supplement 10AP
1986-03-06Manufacturing (CMC) · Supplement 6AP
1985-09-19Manufacturing (CMC) · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →